This is a working overview of glucagon receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-02-03. Anything still debated is marked as such rather than presented as settled.
Verification of research-grade material depends on documentation supplied with a sample. A certificate of analysis lists purity, identity, and the methods used to establish each value. Buyers comparing suppliers look at chromatographic purity figures, mass confirmation data, and whether methods are described in enough detail to be reproduced. Independent testing can confirm reported values but adds cost and time. Because the research chemical market is not uniformly regulated, provenance and documentation quality vary widely, and claims should be evaluated against raw data rather than summary labels.
Characterization of retatrutide in research settings relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase separation resolves the parent peptide from related impurities, while electrospray ionization mass spectrometry confirms molecular mass against a calculated value. Peptide mapping after enzymatic digestion can verify the amino acid sequence. Laboratories often combine orthogonal methods because no single technique establishes both identity and purity. Detected impurities typically include truncated sequences, oxidized residues, and deamidated forms that arise during synthesis or storage.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
| Property | Value | Notes |
|---|---|---|
| Purity method | Reversed-phase HPLC | Ultraviolet detection near 214 nm |
| Identity confirmation | Mass spectrometry | Electrospray ionization |
| Lyophilized storage | Approximately minus 20 °C | Protected from light and moisture |
| Reconstituted storage | Cold, short-term use | Avoid repeated freeze-thaw |
| Typical impurity classes | Truncated, oxidized, deamidated | Assessed relative to main peak |
Stability studies examine how the molecule changes under defined conditions of temperature, humidity, and light exposure over time. Results are used to set storage recommendations and shelf-life limits. In practice, lyophilized peptide material is often stored at low temperatures to slow degradation, while reconstituted solutions are handled more carefully because they are generally less stable. Reported stability data apply to specific formulations and conditions, so extrapolation to other preparations requires caution.
Retatrutide is handled in laboratories mainly as a lyophilized solid for analytical and biochemical research. The peptide is typically supplied as a white to off-white powder and is reconstituted in appropriate solvents before use. Because peptide-based molecules are sensitive to temperature, moisture, and repeated freeze-thaw cycles, proper storage conditions affect both stability and measurement accuracy. Laboratories generally follow documented handling procedures to maintain the integrity of the material across experiments.
Identification and purity assessment rely on established analytical techniques. Reverse-phase high-performance liquid chromatography separates the compound from related impurities and degradation products. Mass spectrometry confirms molecular identity and detects modifications that change the expected mass. Additional methods such as amino acid analysis or capillary electrophoresis may be used for verification. Small differences in sample preparation can influence results, so procedures are usually controlled and documented in detail. Consistency between runs supports confidence in reported values.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Quality control of research material relies on several complementary checks. Purity testing confirms the absence of truncated or oxidized peptide species, while water content and counterion analysis show how much mass comes from salts rather than the peptide itself. Sequence verification through tandem mass spectrometry ensures the correct amino acid chain. Because unregulated suppliers vary widely, independent verification of identity and purity is often necessary before a sample enters experiments.
Documentation plays a practical role in maintaining consistent results across laboratories. Certificates of analysis list purity, identity, and testing methods, and batch numbers allow comparisons between lots. Records of storage temperature and handling history help investigators interpret unexpected findings. When a sample behaves anomalously, reviewing that documentation often reveals whether the cause lies in the material or in the assay conditions.
== External links == Media related to Romanian Revolution of 1989 at Wikimedia Commons Article on justice failing for 942 killed in Revolution on eve of 20th anniversary Video of Nicolae Ceaușescu's final speech in Republican Square Anonymous Photo Essay about the Romanian Revolution of 1989 TV broadcasts from 22 and 23 December 1989 Live TV Broadcast from 22 December 1989 on Hungarian TV (with English subtitles) The Romanian Revolution of December 1989 Academic Article on Feature Films about 1989 Academic Article on Documentaries about 1989
Scott Boatwright, Chief Executive Officer and Board member Adam Rymer, Chief Financial Officer Curt Garner, President, Chief Strategy and Technology Officer Ilene Eskenazi, Chief Legal and Human Resources Officer Jason Kidd, Chief Operating Officer Laurie Schalow, Chief Corporate Affairs Officer Kerry Bridges, Chief Food Safety Officer
== Medical and recreational use == Prescription of dipipanone is discouraged apart from in exceptional circumstances, because of the perceived risk of abuse — the BNF marks the substance as "less suitable for prescribing" along with other older compounds such as pethidine and pentazocine with unusual abuse patterns. The combination with cyclizine leads to a very strong "rush" if the drug is injected, however the tablets contain insoluble binders which can lead to serious injury or death. During the late 1970s to early 1980s in the UK, many deaths were blamed on misuse of this preparation. As supplies became unavailable, opiate users would mix crushed methadone tablets with crushed cyclizine tablets, in an attempt to replicate the effect of Diconal. When taken orally as indicated for pain, the risk of addiction and euphoric potential is similar to that of morphine, The historical deaths linked to misuse of this drug may make this drug distasteful for prescribing doctors.
However, the amount of radium produced globally has always been small in comparison to other elements, and by the 2010s, annual production of radium, mainly via extraction from spent nuclear fuel, was less than 100 grams. In nature, radium is found in uranium ores in quantities as small as a seventh of a gram per ton of uraninite, and in thorium ores in trace amounts. Radium is not necessary for living organisms, and its radioactivity and chemical reactivity make adverse health effects likely when it is incorporated into biochemical processes because of its chemical mimicry of calcium, due to them both being group 2 elements. As of 2018, other than in nuclear medicine, radium has no commercial applications. Formerly, from the 1910s to the 1970s, it was used as a radioactive source for radioluminescent devices and also in radioactive quackery for its supposed curative power. In nearly all of its applications, radium has been replaced with less dangerous radioisotopes, with one of its few remaining non-medical uses being the production of actinium in nuclear reactors.
== Intracrines in biology and cancer == Intracrines involvement in cancer is primarily through their regulation of growth factors, angiogenesis, and cellular signaling networks that contribute to tumor growth and therapy resistance.
Sources: en.wikipedia.org
==== Cannabinoids ==== According to a study published in the August 15, 2004 issue of the journal Cancer Research, cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to gliomas (brain tumors) implanted under the skin of mice, by inhibiting the expression of genes needed for the production of vascular endothelial growth factor (VEGF).
Biocatalyzed kinetic resolution is utilized extensively in the purification of racemic mixtures of synthetic amino acids. Many popular amino acid synthesis routes, such as the Strecker Synthesis, result in a mixture of R and S enantiomers. This mixture can be purified by (I) acylating the amine using an anhydride and then (II) selectively deacylating only the L enantiomer using hog kidney acylase. These enzymes are typically extremely selective for one enantiomer leading to very large differences in rate, allowing for selective deacylation. Finally the two products are now separable by classical techniques, such as chromatography.
==== Knight Grand Cross of the Royal Victorian Order (GCVO) ==== Captain Sir Alastair Sturgis Aird, , Private Secretary and Comptroller to Queen Elizabeth The Queen Mother. General Sir Geoffrey Richard Desmond Fitzpatrick, , Gold Stick.
The pivotal event of Naram-Sin's reign was a widespread revolt against the Akkadian Empire. The empire created by his grandfather, Sargon, first ruler of the Akkadian Empire stretched in the west to Syria in places like Tell Brak and Tell Leilan, to the east in Elam and associated polities in that region, to southern Anatolia in the north, and to the "lower sea" in the south encompassing all the traditional Sumerian powers like Uruk, Ur, and Lagash. All of these political entities had long histories as independent powers and would periodically re-assert their interests throughout the lifetime of the Akkadian Empire.
Zita of Bourbon-Parma (Zita Maria delle Grazie Adelgonda Micaela Raffaela Gabriella Giuseppina Antonia Luisa Agnese; 9 May 1892 – 14 March 1989) was the last Empress of Austria and Queen of Hungary, in addition to other titles. She ascended to these titles when her husband, Charles I, became the last monarch of Austria-Hungary. She was declared Servant of God by Pope Benedict XVI. Born as the seventeenth child of the dispossessed Robert I, Duke of Parma, by his second wife, Infanta Maria Antonia of Portugal, Zita married Archduke Charles of Austria in 1911. Charles became heir presumptive to Emperor Franz Joseph I in 1914 after the assassination of his uncle Archduke Franz Ferdinand of Austria, and acceded to the throne in 1916 after the elderly emperor's death. After the end of World War I in 1918, the Habsburgs were deposed and the former empire became home to the states of Austria, Hungary, and Czechoslovakia, while other parts were annexed to or joined the Kingdom of the Serbs, Croats and Slovenes, Italy, Romania, and a reconstituted independent Poland. Charles and Zita left for exile in Switzerland and, after the failure of attempts to restore royal rule in Hungary, were subsequently removed from that country by the Allies to Madeira, where Charles died in 1922. After her husband's death, Zita and her son Otto served as symbols of unity for the exiled dynasty. A devout Catholic, she raised a large family after being widowed at the age of 29; she never remarried.
Sources: en.wikipedia.org
=== Mortality === CRE resistance depends upon a number of factors such as the health of the patient, whether the patient has recently undergone a transplant, risk of co-infection, and use of multiple antibiotics. Carbapenem minimal inhibitory concentrations (MICs) results may be more predictive of clinical patient outcomes than the current categorical classification of the MICs being listed as susceptible, intermediate, or resistant. The study aimed to define an all-cause hospital mortality breakpoint for carbapenem MICs that were adjusted for risk factors. Another objective was to determine if a similar breakpoint existed for indirect outcomes, such as the time to death and length of stay after infection for survivors. Seventy-one patients were included, of which 52 patients survived and 19 patients died. Classification and regression tree analysis determined a split of organism MIC between 2 and 4 mg/liter and predicted differences in mortality (16.1% for 2 mg/liter versus 76.9% for 4 mg/liter). In logistic regression controlling for confounders, each imipenem MIC doubling dilution doubled the probability of death. This classification scheme correctly predicted 82.6% of cases. Patients were accordingly stratified to MICs of ≤2 mg/liter (58 patients) and ≥4 mg/liter (13 patients). Patients in the group with a MIC of ≥4 mg/liter tended to be more ill. Secondary outcomes were also similar between groups. Patients with organisms that had an MIC of ≥4 mg/liter had worse outcomes than those with isolates of an MIC of ≤2 mg/liter.
The resulting campaign was costly for both sides, but ultimately ended in disaster for France and the near-destruction of Napoleon's Grande Armée. French forces retreated from Russia by December 1812 and began reconstituting their lost strength. Encouraged by the defeat, Austria, Prussia, and several minor powers joined Russia, Britain, and Spain in a Sixth Coalition and began a campaign against France. The Sixth Coalition defeated Napoleon at Leipzig in October 1813. The allies then invaded France on two fronts: the Russians, Austrians, and Prussians invaded France from the east, while the British, Spanish, and Portuguese invaded France from the west. Coalition troops captured Paris in March 1814, forced Napoleon to abdicate in April, exiled him to the island of Elba, and restored power to the Bourbons. Napoleon escaped exile in February 1815 and reassumed control of France for around one hundred days, igniting the eponymous conflict. The allies formed the Seventh Coalition, which defeated him at Waterloo in June 1815 and exiled him to Saint Helena, where he died in 1821. The wars had profound consequences on history. New methods of warfare were introduced, including mass conscription and guerrilla warfare. Politically, the wars greatly influenced Europe through the advancements in civil law brought about by the Napoleonic Code, which was largely retained where it was adopted, and the spread of nationalism and liberalism. Independence movements emerged in Spanish America as a direct consequence of the wars, leading to the decline of the Spanish and Portuguese Empires.
The following is a partial list of the "D" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM). This list continues the information at List of MeSH codes (D12.125). Codes following these are found at List of MeSH codes (D12.776). For other MeSH codes, see List of MeSH codes. The source for this content is the set of 2006 MeSH Trees from the NLM.
== Veterinary use == Ivermectin is routinely used to control parasitic worms in the gastrointestinal tract of ruminant animals. These parasites normally enter the animal when it is grazing, pass the bowel, and set and mature in the intestines, after which they produce eggs that leave the animal via its droppings and can infest new pastures. Ivermectin is only effective in killing some of these parasites, because of an increase in anthelmintic resistance. This resistance has arisen from the persistent use of the same anthelmintic drugs for the past 40 years. Resistance to ivermectin has also been reported in cattle tick (Rhipicephalus microplus) populations from the Brazilian Amazon, including resistant populations identified in western Pará. Additionally, the use of Ivermectin for livestock has a profound impact on dung beetles, such as T. lusitanicus, as it can lead to acute toxicity within these insects. In dogs, ivermectin is routinely used as prophylaxis against heartworm. Dogs with defects in the P-glycoprotein gene (MDR1), often collie-like herding dogs, can be severely poisoned by ivermectin. The mnemonic "white feet, don't treat" refers to Scotch collies that are vulnerable to ivermectin. Some other dog breeds (especially the Rough Collie, the Smooth Collie, the Shetland Sheepdog, and the Australian Shepherd), also have a high incidence of mutation within the MDR1 gene (coding for P-glycoprotein) and are sensitive to the toxic effects of ivermectin. For dogs, the insecticide spinosad may have the effect of increasing the toxicity of ivermectin.
Sources: en.wikipedia.org
Purity is usually reported from reversed-phase high-performance liquid chromatography with ultraviolet detection. Peak area percentage gives a purity figure, though it does not prove identity. Mass spectrometry is used alongside chromatography to confirm the expected molecular mass.
Lyophilized peptide is commonly stored frozen and protected from light and moisture. Dissolved material is kept cold and used quickly because degradation accelerates in solution. Freeze-thaw cycling should be minimized to limit aggregation.
Typical impurities include truncated peptide sequences, oxidized methionine or tryptophan residues, and deamidated forms. These arise during synthesis, purification, or storage. Their levels are reported relative to the main peak in chromatographic analysis.
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.